Hematopoietic progenitor cells circulate in the peripheral blood (PB) of cancer patients during the recovery phase that follows treatment with high-dose cyclophosphamide followed by hematopoietic growth factor infusion. We report that when PB progenitors were exposed in vitro to filtered supernatant from cell line PA317-N2, producing amphotropic helper-free N2 vector at conventional titers, successful retroviral-mediated transfer of neomycin resistance gene was documented by polymerase chain reaction in 93% of day 14 myelomonocytic colonies. Under the same conditions, gene transfer was achieved in 22% of steady-state bone marrowderived myelomonocytic colonies. Neo-resistance gene trans-ENE TRANSFER into human hematopoietic cells by G retroviral vectors is a potential new treatment modality for a variety of genetic and acquired human diseases.' At the present time, the two major obstacles to the clinical application of gene transfer into hematopoietic progenitor/ stem cells are the scarce availability and relative refractoriness of these cells to efficient vector infectioq2 most probably because of their quiescent cell cycle status3 While a possible solution to low gene transfer rate into bone marrow (BM) hematopoietic progenitors may be in vitro induction into the cell cycle with hematopoietic growth factors: the limited availability of target cells from BM remains unsolved. In contrast, very large amounts of hematopoietic progenitors can be retrieved from the peripheral blood (PB) of cancer patients in the recovery phase that follows high-dose cyclophosphamide (HD-CTX) therapy and recombinant human granulocyte-macrophage colonystimulating factor (rhGM-CSF).5,6 Growth factor-exposed PB progenitors comprise different stages of hematopoietic differentiation, possibly including BM repopulating cells,' and actively proliferate, as shown by in vitro culture assays8
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MATERIALS AND METHODS
Target cells. Mononuclear cell-enriched suspensions were obtained from BM or PB of patients with histologically confirmed cancer treated with HD-CTX, 7 g/m2,9 and one of the following hematopoietic growth factors starting on the day after HD-CTX therapy: (1) rhGM-CSF (SandozEchering-Plough, Basel, Switzerland) at 5 pg/kg/d; (2) recombinant human interleukin-3 (rhIL-3; Sandoz) at 5 p,g/kg/d; (3) rhIL-3 for 6 days followed by rhGM-CSF for 8 days; (4) recombinant human granulocyte-CSF (rhG-CSF; AmgedRoche, Thousand Oaks, CA) at 10 kg/kg/d. PB cells were harvested on a large scale by leukapheresis with standard clinical techniques.I0 Leukapheresis cells (median number, 3.9 x lo9; range, 2.3 to 22.6 x 109/bag) comprised a substantial fraction of hematopoietic progenitors, evaluated both by cultural assay as granulomonocytic colony-forming cells (CFU-GM; median, 14.8 x lo6; range, 12.2 to 40.3 X @/bag) and by flow cytometry as CD34 antigen-positive cells (median, 290 x 106, range, 80 to 1,200 x 106/bag). One-to 2-mL aliquots from BM or leukapheresis cell suspension were fractionated by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden), and light-density cells were washed twice with Hanks' balanced salt solution-5% heat-inactivated fetal bovine serum (HBSS-FBS). In some experiments, a preculture step was performed for 48 hours at 37°C in 5% C02 atmosphere in Iscove's modified Dulbecco medium (IMDM; GIBCO, Paisley, UK) with 10% FBS (IMDM-10% FBS) and rhIL-3 (Sandoz) at 75 ng/mL. Growth factors used in combination with rhIL-3 were either rhIL-6 (Hyclone, Logan, UT, a gift from Dr Domenico Trizio) at 10 ng/mL, rhGM-CSF (SandodSchering-Plough) at 75 ng/mL, or stem cell factor (rhSCF; Amgen, Thousand Oaks, CA, a gift from Dr Christina Zsebo) at 100 ng/mL.
The retroviral vector N2, carrying the neomycin resistance gene (neoR gene)," was produced from PA317-N2 amphotropic packaging cell line cultivated in RPMI with 10% heat-inactivated calf serum (a gift from Dr F. Malavasi, University of Turin, Italy). Viral titer ranged from 2 x 105 to 106 cfu/mL. Supernatant from the packaging cell line was found free of helper virus by the L+S-extended method.I2 Aliquots of fresh medium from subconfluent cells were harvested, filtered with 0.22 km filters, and used for infection experiments. One to two million hematopoietic cells, either directly or after the 48 hours of preculture, were exposed to 8 to 10 mL of freshly filtered supernatant from the PA317-N2 cell line for 3 hours at 37°C in the presence of protamine sulfate (Sigma, St Louis, MO) 5 kg/mL,I3 in 25-cm2 flasks (Bibby, Corning, NY). A constant multiplicity of infection close to 5 was maintained for all experiments. After two
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For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From washings with HBSS-FBS, cells were resuspended in IMDM-IO% FBS. After overnight incubation in the presence of growth factors, a 3-hour exposure to PA317-N2 supernatant was repeated. Cells were then washed twice with HBSS-FBS and resuspended in IMDM-IO% FBS for further examination. Control samples were exposed to medium not containing retroviral vectors. Mockinfected cells were exposed to supernatant from the PA332 packaging cell line producing the SDHT~ect0r.l~ Granulomonocytic colonies were grown from control and from N2 transduced progenitor cells by a modification of the limiting dilution liquid culture assay described by Ventura et al.Is Briefly, cells were resuspended in IMDM-10% FBS supplemented with mollL hydrocortisone and hematopoietic growth factors (rhlL-3 at 75 ng/mL, rhGM-CSF at 75 nglmL, rhlL-6 at IO ng/mL, and rhSCF at 100 ng/mL). One to one hundred cells per well were seeded in 60 round-bottom 96-well plates in 0.1 mL and incubated at 37°C in 5% C02 atmosphere. Twenty-four hours later, G418 (GIBCO BRL) was added at two different final concentrations (0.8 and 1.2 mglmL). After 2 weeks in culture, the wells were scored for colony growth using an!inverted microscope. and single colonies were picked up for analySiS .of neoR gene transduction by polymerase chain reaction (PCR). Liquid culture assay was preferred to conventional semisolid medium assay because of the larger size of the colonies and the lack of interference of semisolid medium with PCR analysis. To avoid the presence of more than one clone in a single well, IO or less cells were seeded in each well. Furthermore, only experiments in which positive wells were less than 30% of the total plated wells were selected for analysis. In this case, the probability that a single positive well will contain a clone will be greater than 83%. 16 Retroviral gene transfer in precursors to granulocyte-macrophage colony-forming cells was assessed by a modification of the pre-CFU assay, which has been already described." Briefly, 106 cells from leukapheresis infected with N2 retroviral vector as described above were treated with 100 pmollL maphosphamide (Asta-Werke, Frankfurt, Germany) at 37°C for 30 minutes, washed twice, resuspended in IMDM-10% FBS with rhlL-If3 I 0 0 UlmL and rhlL-3 75 nglmL, and incubated at 37°C in 5% CO2 atmosphere. Cell aliquots were plated in %well plates at a concentration of IO cellslwell before treatment, immediately after maphosphamide treatment, and after 7 and 14 days of incubation with rhlL-l and rhlL3. Colonies from single wells were picked up after 14 days and analyzed for neoR gene transduction by PCR.
Transduction of neoR gene into hematopoietic cells was assessed by PCR.IR Cells from colonies grown in single wells were resuspended in lysis buffer (50 mmollL KCI, 10 mmollLTris-HCI, 2.5 mmollL MgClz, 0.1% gelatin, 0.45% NP40, 0.45% Tween 20, proteinase K 60 pglmL) and incubated at 55°C for 1 hour. After heating at 95°C for 10 minutes, DNA samples were subjected to Hematopoietic pmgenitor cell cultuw.
Pre-colony-fomtingunit (pre-CFU) ussay.
PCR.

1419
PCR amplification using GeneAmp PCR Reagent Kit (Perkin Elmer Cetus, Nomalk, CT) under conditions suggested by the manufacturer. DNA samples were amplified for 35 cycles of denaturation (94°C for 15 seconds), annealing (57°C for 1 minute), and polymerization (72°C for 1 minute) in a thermal cycler. The oligonucleotide primers used for neoR gene amplification were: 5'-ATC ATG G f f GAT GCA ATG CG-3' and 5'-AGA TCA TCC TGA TCG ACA AG-3'. Amplification of neoR gene by these primers resulted in an amplified fragment of 131 bp. After amplification, reaction mixture was analyzed by 2% agarose gel electrophoresis, stained with etidium bromide, and transferred to nylon membranes (NEN Research Products, Boston, MA) by Southern transfer. Filters were hybridized for 16 hours at 42°C to a '?P-labeled neo probe representative of the entire amplified fragment and were washed four times with 0.1% SSC-0.1% sodium dodecyl sulfate (SDS). For autoradiography, filters were exposed to X-ray films at -80°C for 2 hours with the use of intensifying screens.
RESULTS
PB cells obtained from a breast cancer patient during hematopoietic recovery after HD-CTX therapy and rhIL-3 plus rhGM-CSF infusion were cultured in vitro for 48 hours with rhlL-3 plus rhIL-6, and infected by exposure to N2 retroviral vector containing supematant. After 14 days, 17 colonies not selected with (3418 were picked up and analyzed by PCR. Under these conditions, 100% of the colonies (17 of 17) grown from infected cells were PCRpositive (Fig 1 and Table 1 ). PB cells from a further six patients similarly treated with HD-CTX and hematopoietic growth factor(s) were infected with the same procedure; the overall gene transfer rate evaluated as PCR-positive colonies was 93% ( Table 1) . As controls, we subjected to supernatant infection PB and BM cells obtained from patients before HD-CTX therapy and growth factor infusion. PB cells failed to originate colonies ( Table 1) . BM cell infection resulted in 22% PCR-positive colonies, and in 11% (3418-resistant colonies ( Table 1 ). In our experiments, an in vitro preculture step in the presence of hematopoietic growth factors before infection has been used to increase the proliferative activity of hematopoietic progenitors4 (Table l) , because the gene transfer rate has been reported to correlate with the proliferative activity of target cells.3 To evaluate the role of the in vitro preculture, we infected PB progenitors immediately after collection from the patient. Under these conditions, transduction efficiency was 93% as well ( Table 1) G418-resistant colonies are reported as colonies grown from 60 replicates after selection in 1.2 mglmL G418 and without selection, respectively.
Abbreviation: ND. not determined.
PCR-positive colonies are reported as the ratio between positivelanalyzed colonies.
We then evaluated whether viral titer was important for a high transfer rate into PB progenitors. Filtered fresh supernatant from helper-free PA317-N2 cell line at conventional titer (lo6 cfu/mL) was serially diluted with PA317-N2 supernatant that was heat-inactivated at 56°C for 30 minutes, and mixtures were used to infect different aliquots of PB progenitors. Colonies from infected cells were mostly neoR gene-positive at PCR up to 1 to 4 dilution, and 100% negative upon infection with inactive supernatant (Table   To provide evidence that the cell responsible for the long-term reconstitution of myelopoiesis is being transduced, we analyzed neoR gene transfer into a CD34+/ cyclophosphamide-resistant precursor to the granulocytemacrophage colony-forming cell, using the pre-CFU assay developed by Smith et with modifications. After the gene transfer procedure, cells were incubated with maphosphamide. Maphosphamide-treated cells were plated immediately after treatment (day 0) and after 7 and 14 days of culture in rhIL-1 plus rhIL-3. At day 0, no colonies survived, whereas a remarkable number of hematopoietic colonies originated after 7 and 14 days in culture. The latter colonies were 100% neoR gene-positive at PCR analysis (Fig 2) .
Given the tremendous sensitivity of the PCR technique, stringent controls were performed to specifically assess the absence of false positives. PCR analysis was performed on PCR buffer, on colonies from uninfected cells, on colonies 2). Values represent colonies in wells plated with 10 infected cellslwell in 60 replicates. The number of PCR-positive colonies is reported as the ratio between positive/analyzed colonies. from mock-infected cells, on medium from wells without colony growth after 0,5, and 15 days of culture, and on cells infected with heat-inactivated PA317-N2 supernatant. In all these cases, samples were neoR gene-negative by PCR.
DISCUSSION
We have successfully transduced at high efficiency a neomycin resistance gene into PB hematopoietic progenitors in vivo exposed to high-dose chemotherapy and hematopoietic growth factors. This extremely high gene transfer efficiency is not observed when BM is used as the target of retroviral-mediated gene transfer, particularly when the procedure involves supernatant infection, as in this case.' This striking difference in gene transfer rate most likely depends on the fact that circulating progenitors are actively cycling in vivo under the direct or indirect effect of hematopoietic growth factors administered intravenously at the time of hematopoietic progenitor cell harvest by leukapheresis. The question of whether a given growth factor or a given combination confers an advantage in terms of transduction efficiency cannot be answered by our present data, as the majority of our patients received a combination of IL-3 and GM-CSF after HD-CTX, and we did not observe major differences among the gene transfer rates into cells primed with different growth factor(s).
In our experience, PCR analysis was more sensitive in detecting transduced hematopoietic colonies than selection with G418 (93% v 54% overall). Our results should be directly compared with those obtained by PCR analysis on individual colonies, as G418 resistance might underestimate2Jy as well as overestimate*O neoR gene transduction, and its poor standardization does not allow meaningful interstudy comparisons. A critical issue regarding clinical applicability is to determine whether PB progenitors comprise multipotent stem cells and whether these putative stem cells can be transduced. In this report, we have shown that a very primitive C N -G M precursor, which is both CD34+ and cyclophosphamide-resistant, is efficiently infected with the present approach. In previous reports, we have shown that growth factor-exposed PB cells comprise hematopoietic progenitors at different stages of differentiation, as shown by culture assays6aR and by flow cyt0metry.5.~ When retrieved from PB by leukapheresis'" and infused alone in myeloablated patients, these cells provided a complete long-lasting hematopoietic reconstitution highly suggestive of the presence of early progenitors/stem cells.23 Finally, it has been observed that in rodents hematopoietic progenitors circulating in the PB during in vivo G-CSF treatment d o include substantial numbers of the most primitive stem ~ells.2~ Yet, none of these observations can be held as formal proof for the presence of stem cells in the PB of growth factortreated patients. As a corollary, formal evidence for successful transduction into human stem cells also awaits the performance of critical in vivo experiments in humans. Our demonstration that large amounts of hematopoietic progenitors can be transduced at very high efficiency under clinically feasible conditions represents a basic achievement toward this goal. Finally, we wish t o point out that efficient transduction of multipotent hematopoietic progenitors, as shown here, may be of value per se in the clinical setting. In fact, these easily transducible progenitors have a prolonged, although limited, life span, and can thus be clinically exploited whenever the transfer of genes into the stem cell is not an absolute requirement.
